Zepto Expands into 10-Minute Medicine Delivery in Four Major Indian Cities

1 min read     Updated on 07 Aug 2025, 11:29 PM
scanxBy ScanX News Team
whatsapptwittershare
Overview

Quick commerce startup Zepto has launched 'Zepto Pharmacy', offering 10-minute medicine delivery in select areas of Mumbai, Bengaluru, Delhi-NCR, and Hyderabad. The service was introduced after a 12-month pilot phase focusing on operational refinement and regulatory compliance. CEO Aadit Palicha emphasized a steady growth strategy while maintaining high standards. Zepto now competes with established online pharmacies like Tata 1mg, PharmEasy, and Apollo 24/7, potentially disrupting the online pharmacy market with its ultra-fast delivery promise.

16135185

*this image is generated using AI for illustrative purposes only.

Quick commerce startup Zepto has made a significant move into the healthcare sector with the launch of 'Zepto Pharmacy', a service promising medicine delivery within 10 minutes. The new offering is currently available in select areas of Mumbai, Bengaluru, Delhi-NCR, and Hyderabad, marking Zepto's expansion beyond its core grocery delivery model.

Strategic Expansion After Pilot Phase

The launch of Zepto Pharmacy comes after a meticulous 12-month pilot phase. During this period, the company focused on:

  • Refining its operations
  • Strengthening its supply chain
  • Ensuring compliance with regulatory requirements

This careful approach underscores Zepto's commitment to maintaining high standards in the complex and sensitive field of pharmaceutical delivery.

CEO's Vision for Growth

Aadit Palicha, CEO of Zepto, emphasized the company's strategic approach to this new venture. "We plan to grow steadily while maintaining high operational standards, given the category's complexity," Palicha stated. This cautious yet ambitious stance reflects Zepto's understanding of the challenges and responsibilities associated with medicine delivery.

Competitive Landscape

With this expansion, Zepto enters a highly competitive market, positioning itself against established online pharmacies such as:

  • Tata 1mg
  • PharmEasy
  • Apollo 24/7

The move also puts Zepto in direct competition with other quick commerce firms that have ventured into medicine delivery.

Implications for the Healthcare Delivery Sector

Zepto's entry into the 10-minute medicine delivery space could potentially disrupt the online pharmacy market. The promise of ultra-fast delivery for medicines could be particularly appealing to:

  • Customers requiring urgent medication
  • Those with chronic conditions needing regular refills

However, the success of this venture will likely depend on Zepto's ability to maintain the delicate balance between speed and the stringent quality and safety standards required in pharmaceutical distribution.

Looking Ahead

As Zepto rolls out its pharmacy service in these four major cities, the industry will be watching closely to see how this quick commerce model adapts to the unique challenges of medicine delivery. The company's performance in this new sector could set a precedent for the future of healthcare logistics in India's rapidly evolving e-commerce landscape.

Zepto's expansion into pharmacy services represents a bold step for the young company, blending the convenience of quick commerce with the essential nature of healthcare delivery. As the service develops, it will be crucial to observe how Zepto navigates the regulatory environment and meets the high expectations of customers in this critical sector.

like17
dislike

Zepto's Revenue Soars 150% to Rs 11,110 Crore as Investor Plans Additional Stake

1 min read     Updated on 30 Jul 2025, 02:42 PM
scanxBy ScanX News Team
whatsapptwittershare
Overview

Quick commerce startup Zepto has reported a 150% increase in revenue, reaching Rs 11,110 crore from Rs 4,455 crore the previous year. Existing investor Elcid Investments plans to invest up to Rs 7.5 crore more in Compulsorily Convertible Preference Shares at Rs 33.25 per share, potentially owning about 0.0146% of Zepto's fully diluted share capital. Elcid's current stake in Zepto is valued at Rs 18.2 crore.

15412328

*this image is generated using AI for illustrative purposes only.

Zepto , a quick commerce startup, has demonstrated remarkable growth, with its revenue skyrocketing to Rs 11,110 crore, marking a substantial 150% increase from the previous year's Rs 4,455 crore. This impressive financial performance was revealed through regulatory filings by one of Zepto's existing investors, Elcid Investments.

Revenue Surge

Zepto's revenue jump from Rs 4,455 crore to Rs 11,110 crore underscores the rapid expansion and increasing market penetration of the quick commerce sector in India. This growth trajectory positions Zepto as a significant player in the competitive e-commerce landscape.

Investor Confidence

Elcid Investments, already holding a stake in Zepto, has expressed its continued confidence in the company's potential. The investor has outlined plans to further increase its investment in the quick commerce platform.

New Investment Details

Item Value
Proposed Investment Up to Rs 7.5 crore
Investment Instrument Compulsorily Convertible Preference Shares (CCPS)
Share Price Rs 33.25 per share
Potential Ownership Approximately 0.0146% of Zepto's share capital on a fully diluted basis

Existing Investment

Elcid Investments' current stake in Zepto stands at Rs 18.2 crore as of March 2025, indicating the investor's ongoing commitment to the company's growth story.

Market Implications

The substantial revenue growth and continued investor interest suggest strong market demand for Zepto's quick commerce services. This performance could potentially influence the broader e-commerce and delivery sectors, possibly spurring further investments and innovations in the space.

As Zepto continues to expand its operations and attract investments, it will be interesting to observe how this growth impacts the competitive landscape of the quick commerce industry in India.

like18
dislike
Explore Other Articles
Makers Laboratories Reports 18.3% Revenue Growth and Return to Profitability in Q1 5 minutes ago
Puravankara to Launch 12.32 Million Square Feet in Bangalore Projects 4 minutes ago
BAT Awaits RBI Approval for 15.29% Stake Sale in ITC 26 minutes ago
Mini Diamonds (India) Secures $2.15 Million Export Order from Hong Kong Client 19 minutes ago